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Background: Patients diagnosed with cancer by the emergency route often have more advanced diseases and
poorer outcomes. Rates of cancer diagnosed through unplanned admissions vary within and between countries,
suggesting potential inconsistencies in the quality of care. To reduce diagnoses by this route and improve patient
outcomes, high risk patient groups must be identified. This cross-sectional observational study determined the
incidence of first-ever diagnoses of cancer by emergency (unplanned) admission and identified patient-level risk
factors for these diagnoses in England.
Methods: Data for 74,763 randomly selected patients at 457 general practices between 1999 and 2008 were
obtained from the General Practice Research Database (GPRD), including integrated Hospital Episode Statistics (HES)
data and Office for National Statistics (ONS) mortality data. The proportion of first-ever diagnoses by emergency
admission out of all recorded first cancer diagnoses by any route was analysed by patient characteristics.
Results: Diagnosis by emergency admission was recorded in 13.9% of patients diagnosed with cancer for the
first time (n = 817/5870). The incidence of first cases by the emergency route was 2.51 patients per 10,000 person
years. In adjusted regression analyses, patients of older age (p < 0.0001), living in the most deprived areas (RR 1.93,
95% CI 1.51 to 2.47; p < 0.0001) or who had a total Charlson score of 1 compared to 0 (RR 1.34, 95% CI 1.06 to 1.69;
p = 0.014) were most at risk of diagnosis by emergency admission. Patients with more prior (all-cause) emergency
admissions were less at risk of subsequent diagnosis by the emergency route (RR 0.31 per prior emergency
admission, 95% CI 0.20 to 0.46; p < 0.0001).
Conclusions: A much lower incidence of first-ever cancer diagnoses by emergency admission was found
compared with previous studies. Identified high risk groups may benefit from interventions to reduce delayed
diagnosis. Further studies should include screening and cancer staging data to improve understanding of delayed
or untimely diagnosis and patient care pathways.
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Improving cancer outcomes is an international health
priority, including the reduction of diagnoses through the
emergency route. Patients who are diagnosed by emer-
gency (or unplanned) admission typically have more
advanced diseases and poorer outcomes such as survival,
especially older patients [1-5]. The term “emergency” is* Correspondence: c.tsang@imperial.ac.uk
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reproduction in any medium, provided the oroften used synonymously with “unplanned” admissions
and is applied as such in this paper. Emergency admis-
sions are characterised as arising through Accident and
Emergency (A&E) services, general practitioner (GP), bed
bureau, outpatient clinic or other means which may
include the A&E department of another care provider [6].
To reduce delayed or untimely diagnoses, factors influen-
cing patients’ access to services before diagnosis, including
pre-referral general practice consultations, must be bet-
ter understood and especially in high risk patient
groups [7,8].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the emergency route in England [9-11]. However, the
rate of these admissions varies across the country,
suggesting that there are inconsistencies and delays in
local services [4,9,12]. Using national data from hospitals
in England (Hospital Episode Statistics, HES), we previ-
ously identified patient and general practice characteris-
tics associated with increased risk of cancer diagnosis by
emergency admission [11]. When data from only one
care setting are analysed, inclusion of false positive cases
or incomplete capture of cases may occur [11,13,14].
Elliss-Brookes et al. (2012) used HES linked with cancer
registry, cancer screening and cancer waiting times data
to examine routes to diagnosis, but their study period
was only two years between 2006 and 2008 [10]. In our
current study, the accuracy of case ascertainment (cor-
rect identification of patients with a first-ever emer-
gency admission for cancer) was improved by linking
hospital data with primary care data for a ten-year
study period.
Studies in England have described patient risk factors
for diagnosis by emergency admission for some cancers,
such as breast, colorectal, oesophageal, gastric and lung
cancers [4,13]. Unlike previous research focusing on
specific types, this study examined all cancers. We inves-
tigated predictors of first-ever emergency admissions for
cancer, as a proxy for first-ever delayed or untimely diag-
nosis by the emergency route. We also determined the
incidence of these admissions from first-ever cancer
diagnoses by any diagnosis route.Methods
General practice research database
National data were obtained from the General Practice
Research Database, GPRD (superseded by the Clinical
Practice Research Datalink, CPRD, since April 2012),
under a Medical Research Council (MRC) licence for
academic institutions. The GPRD is one of the largest
electronic patient-level, anonymised primary care data-
bases in the world. It includes clinical and non-clinical
data, which can be linked with other data sources such
as disease registries. It is renowned for its represen-
tational coverage of the English population and is well
validated for epidemiological and biomedical research,
including studies on cancer [15-20]. GPRD performs
preliminary data cleaning to ensure that the data are
of a consistent acceptable standard for research pur-
poses (up-to-standard, UTS). The study population
was drawn from patients whose records were deemed
“acceptable” and who were registered at practices with
an UTS date during the study period. Data were
extracted from the October 2010 build of the GPRD
database.Integrated dataset
Read codes are the current standard clinical classifica-
tion system for English primary care, consisting of a
comprehensive set of medical and non-medical terms
within a structured hierarchy [21]. The Unified 5-Byte
Version 2 Read codes recorded in GPRD can be mapped
to ICD-10 codes, which are used in secondary care and
recorded in HES [21]. Cross-mapping of Read and ICD-
10 codes was performed using the NHS Health and
Social Care Information Centre’s NHS Clinical Termi-
nology Browser Version 1.04.
Integrated emergency admissions data from HES, cen-
tral mortality data from the Office for National Statistics
(ONS) and patient-level social deprivation by Index of
Multiple Deprivation (IMD) 2007 scores were available
in the dataset. Patient-level linkage by National Health
Service (NHS) number, date of birth and sex was carried
out internally by GPRD before the anonymised dataset
was distributed to the authors.
The raw GPRD dataset contained records for 100,000
patients registered at 584 participating general practices
during the study period (1st January 1999 to 31st
December 2008). Patients with invalid or missing sex,
registration date, year of birth or place of residence (not
in England) were excluded from analyses. The majority
of exclusions were due to non-English residence. Patients
recorded as residing in Northern Ireland, Scotland and
Wales were excluded as HES data only includes admis-
sions to hospitals in England. The cleaned study dataset
contained records for 74,763 patients who were registered
at 457 general practices between 1999 and 2008.Study sample
Eligible patients were those who had a first-ever cancer
diagnosis recorded in general practice records or second-
ary care (HES) between 1st January 1999 (or first consul-
tation date, whichever occurred last) and 31st December
2008 (or date of transfer out of the practice or death,
whichever occurred first). Where patients had one or
more transfers out of a general practice, only data from
the first registration period were included.Cases of first-ever diagnosed cancer
Cancers diagnosed by emergency admission were de-
fined by ICD-10 codes (C codes) and assigned into one
of the 22 cancer categories used by the National Cancer
Intelligence Network (NCIN), which are also based on
ICD-10 codes [22]. Patients diagnosed with cancer by
non-emergency routes were identified by a recorded
primary care cancer diagnosis (Read Codes, B0-B6) and
who did not have a HES record of an emergency admis-
sion for cancer whose date preceded the primary care
record. Case ascertainment was achieved using the
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the datasets.
Patients diagnosed with other malignant neoplasms
(non-melanoma) of the skin or multiple site neoplasms
were excluded (Read B33 and ByuE codes, ICD-10 C44 and
C97 codes, respectively) (see Additional file 1: Table S1). To
improve the accuracy of identifying first-ever diagnoses, we
tracked back to the patient’s first record in the study dataset
obtained from the GPRD. The frequency of cancer types by
diagnosis route (emergency versus non-emergency routes)
was explored by a crude match of ICD-10 to Read codes
(see Additional file 2: Table S2). Patients with a recorded
valid Read or ICD-10 cancer code before the study period
were excluded.
Patient and practice characteristics
Except for the geographical region of the general prac-
tice (categorised into Strategic Health Authorities), no
other practice characteristics were available in the GPRD
dataset. Therefore, mainly patient variables were used: age
at diagnosis; sex; ethnicity; deprivation status; comor-
bidities; continuity of care; follow-up time; length of time
registered at the practice; the number of consultations at
the general practice, by telephone or home visit with a GP
or nurse; referrals and admissions before diagnosis; and
practice region. Ethnicity and social deprivation details
were only available through the linked HES data for
patients who had at least one recorded (any cause) emer-
gency admission.
Comorbidity was measured by a Read code adaptation
of the Charlson Index by Khan et al. (2010), derived
from Deyo et al’s modified version using ICD-9-CM
codes [23]. Each patient’s cumulative comorbidity score
can be estimated from predefined weights for certain
diseases and conditions included in the Index. A three-
banded aggregation of patients’ total Charlson Index
score was applied, grouped as score of 0, 1 and at least
2. Continuity of care was measured by the Bice and
Boxerman’s Continuity of Care (COC) Index [24]. This
Index takes into account the total number of consulta-
tions (at the general practice or by telephone) as well as
the number of visits to each clinician (GPs or nurses)
and the number of clinicians consulted over a fixed time
period [24]. Follow-up time was defined as the length of
time (in years) between study entry (1st January 1999 or
first consultation date, whichever occurred last) and the
first recorded diagnosis of cancer (before or on 31st
December 2008, or date of transfer out of the practice or
death, whichever occurred first).
Statistical methods
The Mann Whitney U test was used in preliminary
descriptive analyses of non-normally distributed ordinal
data. Crude and adjusted analyses were performed bymodified Poisson regression, with a log link function to
generate relative risks. Pre-empting potential problems
of misclassification and effect overestimation due to the
application of Poisson regression for a binary outcome,
the Generalized Estimating Equation (GEE) method was
used [25-28]. This approach also accounted for cluster-
ing of patients at general practices [26]. The stepwise
method was used to select variables for retention in the
adjusted model. An advantage of stepwise selection is
the reduction of multicollinearity, which in this study
may occur due to variables such as age, time at practice
and follow up time; as well as prior consultations and
referrals. To determine entry and stay in this model, a
p-value of 0.05 was used as the cut-off. All analyses
were performed in SAS (version 9.2) and regression
analyses were performed using the “PROC GENMOD”
procedure.
Ethics approval
The GPRD Group has Trent Multi-Centre Research Ethics
Committee approval for all observational research using
GPRD data (reference: 05/MRE04/87). This study was




Out of 74,763 patients in the sample, 5870 (7.85%)
patients who were registered at 445/457 general practices
had a first-ever recorded diagnosis of cancer between
1999 and 2008. Of these patients, 13.9% were diagnosed
during an emergency admission (n = 817/5870). Through
this route and based on NCIN’s cancer categories, the
three most common types of cancers were “other” (21.4%;
n = 193/902), breast (13.6%; n = 123/902) and colorectal
(11.5%; n = 104/902) cancers (Table 1) [22]. Patients
diagnosed by emergency admission had up to two cancer
diagnoses for that episode of care, with 1.45% of patients
recorded as having dual first-ever cancer diagnoses (n =
85/5870). Cancers of the bone, connective tissue, skin and
breast were most frequently recorded out of all cancer
diagnosis codes recorded in both emergency and non-
emergency routes (57.2%, n = 309/540). Due to imperfect
matching between Read and ICD-10 codes, lower level
categorisation was not possible.
Incidence of cancer diagnosis by emergency admission
The incidence of first-ever recorded diagnoses of cancer
by emergency admission during the study period was
2.51 patients per 10,000 person years. Over the ten
years, the rate of cancer diagnoses by the emergency
route declined, with a slight fluctuation in the penulti-
mate year, 2007 (Figure 1). The incidence over the study
period was higher in male patients but the greatest
Table 1 Number of diagnoses by cancer type for first
cancer diagnoses by emergency admission, n = 902
diagnoses
Cancer type Frequency, n (%)












Brain & central nervous system 16 (1.77)




Chronic leukaemia 9 (1.00)



































Figure 1 Incidence of first cancer diagnoses by emergency admission
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5.77 patients per 10,000 person years in 1999 to 2.98
patients per 10,000 person years in 2008. Compared with
patients aged between 15 and 64 years old, the most
marked decline in new cancer diagnoses by emergency
admission was in patients aged 65 years or older, from
7.10 patients per 10,000 person years in 1999 to 3.94
patients per 10,000 person years in 2008. Yet, as Table 2
shows, almost half of first diagnoses by emergency
admission were in patients aged between 65 and 84 years
(48.2%, n = 494/817).
Crude risk factors for diagnosis by emergency admission
In unadjusted regression analyses, all included variables
were predictive of diagnosis by emergency admission.
Age at diagnosis, social deprivation status (where depri-
vation was known), length of time registered at the prac-
tice and follow-up time had positive relationships with
diagnosis by the emergency route (Table 2). Female
patients were less at risk of diagnosis by this route than
male patients (RR 0.73, 95% CI 0.64 to 0.84; p < 0.0001).
Compared with patients registered at practices in Yorkshire
& The Humber, patients of practices in the East of
England (RR 1.31, 95% CI 1.01 to 1.70; p = 0.041),
North West (RR 1.34, 95% CI 1.01 to 1.77; p = 0.041) or
the South East coast (RR 1.49, 95% CI 1.13 to 1.95;
p < 0.004) were most at risk of a first-ever cancer diag-
nosis by emergency admission. Patients with a mode-
rate comorbidity score as measured by a total Charlson
Index score of 1 were at higher risk compared with2004 2005 2006 2007 2008
Year
males Overall
in England, by sex and year (1999-2008).
Table 2 Risk factors for first diagnosis of cancer, crude and adjusted results from Poisson regression using the






RR (95% CI) P-value RR (95% CI) P-value
Age group at diagnosis (years) <.0001 <.0001
0–14 439 8 (0.98) 0.04 (0.02–0.08) <.0001 0.11 (0.06–0.21) <.0001
15–44 2347 61 (7.47) 0.06 (0.04–0.08) <.0001 0.13 (0.10–0.17) <.0001
45–64 1680 259 (31.7) 0.34 (0.27–0.42) <.0001 0.52 (0.44–0.63) <.0001
65–84 1197 394 (48.2) 0.72 (0.57–0.90) 0.004 0.73 (0.60–0.87) 0.001
≥85 207 95 (11.6) 1 1
Sex <.0001 -
Male 2418 400 (49.0) 1
Female 3452 417 (51.0) 0.73 (0.64–0.84) <.0001
Ethnicity <.0001 <.0001
Asian 29 6 (0.73) 4.48 (1.98–10.1) <.0001 3.02 (1.67–5.48) <.0001
Black 30 8 (0.98) 5.77 (2.84–11.7) <.0001 2.09 (1.53–2.87) <.0001
White 1924 617 (75.5) 6.94 (5.87–8.20) <.0001 3.14 (2.48–3.98) <.0001
Other 36 8 (0.98) 4.81 (2.37–9.76) <.0001 3.06 (2.10–4.47) <.0001
Unknown 3851 178 (21.8) 1 1
Deprivation <.0001 <.0001
Least deprived 716 132 (16.2) 2.95 (2.36–3.68) <.0001 1.60 (1.27–2.02) <.0001
Quintiles 2,3,4 1738 382 (46.8) 3.51 (2.95–4.19) <.0001 1.81 (1.47–2.23) <.0001
Most deprived 426 116 (14.2) 4.35 (3.45–5.49) <.0001 1.93 (1.51–2.47) <.0001
Unknown 2990 187 (22.9) 1 1
Charlson Index score <.0001 0.019
0 5785 745 (91.2) 1 1
1 43 39 (4.77) 7.04 (5.10–9.72) <.0001 1.34 (1.06–1.69) 0.014
≥2 42 33 (4.04) 6.10 (4.31–8.65) <.0001 0.87 (0.70–1.07) 0.180
Practice region <.0001 -
East Midlands 122 5 (0.61) 0.32 (0.13–0.79) 0.013
East of England 835 140 (17.1) 1.31 (1.01–1.70) 0.041
London 345 51 (6.24) 1.16 (0.82–1.63) 0.400
North East 252 38 (4.65) 1.18 (0.81–1.72) 0.388
North West 615 105 (12.9) 1.34 (1.01–1.77) 0.041
South Central 763 92 (11.3) 0.94 (0.71–1.26) 0.695
South East Coast 622 118 (14.4) 1.49 (1.13–1.95) 0.004
South West 834 84 (10.3) 0.79 (0.59–1.06) 0.114
West Midlands 746 90 (11.0) 0.95 (0.71–1.26) 0.699
Yorkshire & The Humber 736 94 (11.5) 1
Time at practice (years) <.0001 -
Low 1957 176 (21.5) 1
Moderate 1957 279 (34.2) 1.59 (1.31–1.91) <.0001
High 1956 362 (44.3) 2.06 (1.72–2.46) <.0001
Follow-up time (years) <.0001 -
<1 988 82 (10.0) 0.45 (0.35–0.57) <.0001
1–3 2032 271 (33.2) 0.72 (0.60–0.85) <.0001
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Table 2 Risk factors for first diagnosis of cancer, crude and adjusted results from Poisson regression using the
generalized estimating equations (GEE) method (Continued)
4–6 1571 226 (27.7) 0.77 (0.64–0.93) 0.006
7–10 1279 238 (29.1) 1
Continuity of care <.0001 <.0001
Low 164 134 (16.4) 1 1
Moderate 162 131 (16.0) 0.99 (0.78–1.26) 0.933 1.04 (0.90–1.20) 0.625
High 166 143 (17.5) 1.05 (0.83–1.33) 0.660 1.00 (0.87–1.15) 0.976
Not valid* 5378 409 (50.1) 0.09 (0.08–0.11) <.0001 0.28 (0.24–0.33) <.0001
Consultation ≤30 day before diagnosis† <.0001 -
0 5734 704 (86.2) 1
1 136 113 (13.3) 6.77 (5.55–8.25) <.0001
Referral ≤30 days before diagnosis‡ 0.022 -
Admission before diagnosis, mean (SD) 0.04 (0.20) 0.12 (0.33) 0.30 (0.21–0.43) <.0001 0.31 (0.20–0.46) <.0001
*Patient had fewer than 2 consultations with a GP or nurse at the practice or by telephone during the study period.
†At practice, by telephone, or home visit, with a GP or nurse.
‡Results for dichotomous “referral ≤30 days before diagnosis” variable omitted due to small numbers.
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p < 0.0001).
Adjusted risk factors for diagnosis by emergency
admission
As comorbidity is an important factor in cancer diagno-
sis and treatment, the stepwise model that included this
variable was considered the final adjusted model,
containing 6 out of the original 12 risk factors of inter-
est. Once adjusted for other factors and taken into
account clustering of patients at general practices, pa-
tient’s age at diagnosis, ethnicity, deprivation status,
comorbidities (Charlson Index score), continuity of care
and number of all-cause emergency admissions before
diagnosis remained significant predictors of first-ever
cancer diagnosis by the emergency route.
Two of the 6 patient characteristics continued to dis-
play the monotonic trends detected in crude analyses:
the risk of diagnosis by emergency admission increased
with age and deprivation, p < 0.0001 for each variable.
Compared to patients with unknown ethnicity status,
patients of white ethnicity remained at greatest risk of
diagnosis by emergency admission (RR 3.14, 95% CI 2.48
to 3.98; p < 0.0001). Patients with a moderate comorbidity
score, measured by a total Charlson score of 1 compared
to a score of 0, also remained more at risk of cancer diag-
nosis by the emergency route (RR 1.34, 95% CI 1.06 to
1.69; p = 0.014).
Service use
Within the 30 days immediately before diagnosis, 0.46%
of patients diagnosed via non-emergency routes had one
or more consultations with a GP or nurse at their
general practice, by telephone or home visit (mean 0.01,SD 0.08 consultations) compared with 13.8% of patients
diagnosed by emergency admission (mean 0.25, SD 0.81
consultations), p < 0.0001. Although this factor was cru-
dely associated with the risk of diagnosis by emergency
admission, it was no longer statistically significant once
adjusted for other factors and clustering of patients at
practices (p = 0.124). Regardless of the route to diagno-
sis, the numbers of all-cause emergency admissions and
referrals before the first cancer diagnosis and during the
study period were low, with fewer than 5 patients
recorded as having one or more referrals in the 30 days
prior to diagnosis. In patients diagnosed via the emer-
gency route, 3.3% had at least one prior admission during
the study period (n = 27/817, maximum 2 admissions per
patient) compared with 12.3% of patients diagnosed via
non-emergency routes (n = 619/5053, maximum 3 admis-
sions per patient), p < 0.0001. After adjustment, the num-
ber of prior emergency admissions remained inversely
associated with risk of subsequent diagnosis through the
emergency route (RR 0.31 per prior emergency admission,
95% CI 0.20 to 0.46; p < 0.0001).
Discussion
Summary of findings
In this cross sectional observational study, we explored
temporal trends in first-ever cancer diagnoses by emer-
gency admission in England between 1999 and 2008.
Adjusted analyses highlighted patient groups at greater
risk of diagnosis by this route. These groups included
older patients and those living in the most deprived
areas, as found in other studies [9,29]. Even though the
number of patients who had at least one previous all-
cause emergency admission was small, this characteristic
was associated with lower risk of subsequent cancer
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ies, we did not find regional variation in diagnoses by
emergency admission once adjusted for other factors
[11]. Encouragingly, we found a reduction in the rate of
first cancer diagnoses by the emergency route over time,
which suggests that initiatives to improve cancer aware-
ness in primary care and to improve access to cancer
services may be having positive effects.
Comparison with other studies
Our finding that 13.9% of diagnoses were made during
an emergency admission is similar to the estimate of
12.9% from the National Audit of Cancer Diagnosis in
Primary Care which also included emergency referrals,
and 16.4% of oesophagogastric cancers by Palser et al.,
2013 [9,29,30]. However, our finding is lower than the
estimate of 24% from NCIN, which was calculated from
a combination of HES, cancer registry, and screening
data as well as Cancer Waiting Times, and our earlier
study which used HES data [9-11]. The discrepancy
between earlier estimates and ours here may be due to
differences in case assignment (diagnosis during two or
three years compared with first-ever diagnosis, respec-
tively) [31]. Compared to other sources such as cancer
registries, GPRD data have produced a lower incidence
of cancer but the GPRD also appears to contain valid
and reliable records of cancer diagnoses [19,20].
Previous studies have found regional variations in the
incidence of cancer and patient outcomes but in this
study we found no statistically significant difference by
practice region in the risk of diagnosis by emergency
admission [4,9,12]. Our finding may be due to the rela-
tively small sample size and more research is required
for validation. Similarly, sex was also no longer statisti-
cally significant in adjusted regression analyses. This
finding may again be due to the sample size or the
cancer types included in the study. With known sex-
differences in risk and outcomes by different types of
cancers, further research and especially studies by cancer
type should continue to consider sex as a potential pre-
dictor [8,11,16,20].
Poor access to primary care services is one explanation
for delayed diagnoses including those made by the emer-
gency route, although the relationship is likely to be com-
plex [4,11,32]. While the number of consultations with
GPs or nurses in the 30 days immediately before diagnosis
was not a statistically significant risk factor once all other
factors had been considered, a much greater proportion of
patients diagnosed by emergency admission also consulted
with a GP or nurse in the preceding 30 days compared
with patients diagnosed by non-emergency routes (13.8%
compared with 0.46%, respectively). Lyratzopoulos et al.
(2012) also found variation in pre-referral consultations by
age, sex, ethnicity, and cancer type [8]. Further explorationof this phenomenon in patients with potentially delayed
or untimely and/or late diagnosis is warranted to deter-
mine if “alarm” symptoms are being overlooked [16].
Strengths and limitations
Our study benefitted from the use of linked primary and
secondary care data combined with mortality data from
the GPRD. Cancer registry data are typically considered
the gold standard for research on cancer incidence and
patient outcomes. However, both GPRD and HES data
have shown comparable completeness to cancer registries
[19,33]. The integrated data are likely to improve the
accuracy of patient identification beyond that achieved in
previous studies [11,13,14,29,34]. We applied rigorous
sampling criteria, tracking back to patients’ first records
and cross-referenced between data from primary and
secondary care, to capture patients’ first-ever diagnoses.
Our sampling method is therefore more specific than
other studies that used shorter timeframes for case ascer-
tainment, such as Raine et al. (2010) and Bottle et al. (2012)
who used one-year and three-year look-back periods
respectively [11,13]. Furthermore, the United Kingdom
offers universal health coverage to its population, including
registration with a GP, and people can only be registered
with one general practice at a time [35]. This makes the
data collected by GPs in their electronic patient records a
very valuable resource for research [36].
Limitations of this study include the lack of analysis by
cancer type, which would be useful to inform clinical
practice and management, especially given known differ-
ences in symptoms, treatments and prognoses between
cancers. We performed our analyses at the patient level
and not by cancer type because a minority of patients
had dual first-ever diagnoses. Another reason for this
approach was the lack of precise cross-mapping between
Read codes and ICD-10 codes for cancer diagnoses that
are required for analyses by cancer type. A further meth-
odological consideration is that despite facilitating the
accurate capture of first-ever diagnoses, our sampling
method prevented the inclusion of patients diagnosed
with secondary or recurrent cancers and patients not
diagnosed with cancer for the first-ever time. However,
the service-seeking behaviours and care pathways of
patients defined as such may differ from patients with a
first-ever diagnosis of cancer. Thus, it was appropriate
for this study to exclude these patients, but these patient
groups may be of interest for further study. Our findings
may also be affected by missing data for some variables,
such as ethnicity and social deprivation, although the
risk factors identified in this study are supported by
empirical evidence. As the modified Charlson Index was
mapped using an ICD-9-CM based scoring method,
there may have been inaccurate and incomplete co-
morbidity matching to Read and ICD-10 diagnosis
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the relatively low number of patients with recorded
comorbidity.
We applied stepwise selection despite known limitations
of this procedure, such as sensitivity to variable ordering
and combinations. To select the final regression model,
we considered a full model and those using forward, back-
ward and interactive-forward approaches. There was little
difference between the models in fit or the variables
retained, in support of the appropriate use of stepwise
selection in this study. The interval between initial
primary care presentation and referral for the four main
cancers (breast, colorectal, lung and prostate) is longer
than 30 days for a large proportion of diagnosed patients
[29,37]. For this reason, a longer time interval, such as a
window of the prior 3 months, may be more suitable
when examining patterns in consultations preceding
cancer diagnosis [1,37]. Referral rates for suspected
cancer differ across the country [12,29,38,39]. Unfortu-
nately, the quality of related data was poor in the study
dataset and little interpretation of the results for refer-
rals can be made without validation using other data
sources.
Conclusions
Despite robustness in case identification from the linked
data, to better understand why some patient groups are
more susceptible to delayed and potentially late diagno-
sis by emergency admissions, cancer staging and treat-
ment data are needed [38]. Further data on cancer
screening and waiting times between intervals of care
will help to establish which groups are most affected by
untimely referral and/or diagnosis, and also identify
which elements of the care pathway should be targeted
for improvement [10].
Our population-based analyses have used recent data
to determine a range of patient characteristics associated
with first-ever diagnoses of cancer by the emergency
route as a proxy measure of delayed diagnosis. The results
contribute to national efforts to improve cancer care in
England by increasing understanding of patient groups at
high risk of untimely diagnosis [9,29,40]. This research
focused only on the beginning of the patient cancer
pathway and attention must also be given to the entire
continuum, including better methods of identifying alarm
symptoms in primary care, referral for specialist care, and
long-term patient outcomes.
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